Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2026

Study Completion Date

January 1, 2028

Conditions

Pancreatic Cancer

Interventions

DRUG

Gemcitabine

1000 mg per square meter

DRUG

Nab paclitaxel

120 mg per square meter of body-surface area

Trial Locations (1)

RECRUITING

Shanghai Cancer Center, Shanghai

All Listed Sponsors

lead

Fudan University

OTHER